Singapore-based health startup Neuome Peptides Pte. Ltd has laid the foundation stone for a manufacturing facility at AP MedTech Zone in Vizag. Neuome Peptides is a company that specializes in peptides-based applied technologies for medical diagnostics and therapeutics. 

The foundation stone for the Singapore-India Global Hub for Technologies (SIGHT) was laid on Wednesday. Elaborating on the facility, Neuome Peptides CEO and co-founder Dr. Rajani Kanth Vangala said on Thursday that it was one of the first companies to be part of the hub to manufacture its products in India. 

Neuome, after its recent breakthrough – the ICMR-approved TruCoV-Flow, an ultra-sensitive Covid-19 saliva-based Rapid Antigen Test kit that gives results in two to three minutes - - developed two more products, TruCov-Breath and TruCov-Air which will be manufactured at the Vizag facility. 

He also said that cardiovascular diseases (CVDs) were the leading cause of death (32 percent) globally. Therefore, Neuome Peptides has started its cardiovascular disease instant diagnostic test kit to help those suffering from cardiac noncommunicable diseases (NCD). 

The cardiac NCD DIY and clinical use device called TruHeart is slated to be launched in the latter half of the financial year 2022-23. It is a one-of-a-kind simple, fast, and do-it-anywhere cardiac biomarker test kit that can empower clinicians and populations at large who are not medically exposed to be prepared against the deadliest cardiovascular diseases that claim 17.9 million lives globally per year. 

He added that with one drop of blood, the proprietary test can detect cardiac markers by using specific peptides that can bind at more than one binding site on these biomarkers when conjugated to small gold nanoparticles and can give results within 15-30 seconds. 

Dr. Rajani Kanth also said that Tru-Heart would help in bringing down mortality and enable better healthcare by just using one drop of blood and tests can be done at home, in ambulances, emergency wards, and other points of care and instant results would greatly help in deciding the best emergency treatment protocols.